Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201

Pediatric Oncology Group (POG) protocol 9201 enrolled children with lesser-risk B-lineage acute lymphoblastic leukemia (ALL) defined by age (1-9), white blood cell count (WBC) less than 50 × 10(9)/L (50 000/μL), DNA findings of trisomies 4 and 10 (or DNA index > 1.16), and lack of overt central n...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chauvenet, Allen R., Martin, Paul L., Devidas, Meenakshi, Linda, Stephen B., Bell, Beverly A., Kurtzberg, Joanne, Pullen, Jeanette, Pettenati, Mark J., Carroll, Andrew J., Shuster, Jonathan J., Camitta, Bruce
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2007
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1939894/
https://ncbi.nlm.nih.gov/pubmed/17442849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-12-061689
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados